Research Article

Effects of a Novel Glucokinase Activator, Dorzagliatin, on Glycemic Control and Glucose Fluctuation in Drug-Naïve Patients with Type 2 Diabetes Mellitus

Figure 3

The 24-h glucose variation profiles (a) and the incremental area under glucose concentration versus time curve from 0 to 2 h (iAUC0–2 h) after breakfast, lunch, and dinner (b) of the patients before and after HMS5552 administration, with values presented as the mean. , , and . Error bars show SEM.
(a)
(b)